MedPath

Neurotronik, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:1

Trial Phases

1 Phases

Not Applicable:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Not Applicable
3 (100.0%)

Cardiac Output Autonomic Stimulation Therapy for Heart Failure - Hemodynamic Effects

Not Applicable
Conditions
Heart Failure
Heart Failure Acute
First Posted Date
2018-05-31
Last Posted Date
2018-08-23
Lead Sponsor
NeuroTronik Inc.
Target Recruit Count
30
Registration Number
NCT03542123
Locations
🇵🇾

Sanatorio Italiano, Asunción, Paraguay

Cardiac Output Autonomic Stimulation Therapy for Acute Heart Failure (COAST-AHF)

Not Applicable
Conditions
Heart Failure Acute
First Posted Date
2017-05-30
Last Posted Date
2018-08-23
Lead Sponsor
NeuroTronik Inc.
Target Recruit Count
40
Registration Number
NCT03169803
Locations
🇵🇦

Hospital Punta Pacífica, Panama City, Panama

Cardiac Output Autonomic Stimulation Therapy for Heart Failure (COAST-HF) - Human NeuroCatheter Study

Not Applicable
Completed
Conditions
Cardiac Output, Low
First Posted Date
2016-08-26
Last Posted Date
2016-10-13
Lead Sponsor
NeuroTronik Inc.
Target Recruit Count
16
Registration Number
NCT02880683
Locations
🇵🇾

Sanatorio Italiano, Asuncion, Paraguay

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.